These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3286503)

  • 1. Synthetic peptides of Shiga toxin B subunit induce antibodies which neutralize its biological activity.
    Harari I; Donohue-Rolfe A; Keusch G; Arnon R
    Infect Immun; 1988 Jun; 56(6):1618-24. PubMed ID: 3286503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxy-terminal peptides from the B subunit of Shiga toxin induce a local and parenteral protective effect.
    Harari I; Arnon R
    Mol Immunol; 1990 Jul; 27(7):613-21. PubMed ID: 2203962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic peptides of Shiga toxin B-subunit induce antibodies which neutralize the biological activities of the toxin.
    Harari I; Donohue-Rolfe A; Keusch GT; Arnon R
    Ann Sclavo Collana Monogr; 1986; 3(1-2):125-30. PubMed ID: 3322336
    [No Abstract]   [Full Text] [Related]  

  • 4. Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin.
    Boyd B; Richardson S; Gariepy J
    Infect Immun; 1991 Mar; 59(3):750-7. PubMed ID: 1705242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory immunoglobulin A response to Shiga toxin in rabbits: kinetics of the initial mucosal immune response and inhibition of toxicity in vitro and in vivo.
    Keren DF; Brown JE; McDonald RA; Wassef JS
    Infect Immun; 1989 Jul; 57(7):1885-9. PubMed ID: 2659525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery.
    Levine MM; McEwen J; Losonsky G; Reymann M; Harari I; Brown JE; Taylor DN; Donohue-Rolfe A; Cohen D; Bennish M
    J Clin Microbiol; 1992 Jul; 30(7):1636-41. PubMed ID: 1629317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and biological characterization of shiga toxin from Shigella dysenteriae 1.
    Brown JE; Griffin DE; Rothman SW; Doctor BP
    Infect Immun; 1982 Jun; 36(3):996-1005. PubMed ID: 7047403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of polyclonal and monoclonal antibody responses to cholera toxin by the synthetic peptide approach.
    Ghose AC; Karush F
    Mol Immunol; 1988 Mar; 25(3):223-30. PubMed ID: 3374493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of a humoral immune response to a Shiga toxin B subunit epitope expressed as a chimeric LamB protein in a Shigella flexneri live vaccine strain.
    Ryd M; Verma N; Lindberg AA
    Microb Pathog; 1992 Jun; 12(6):399-407. PubMed ID: 1381804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin.
    Qadri F; Mohi MG; Azim T; Faruque SM; Kabir AK; Albert MJ
    J Diarrhoeal Dis Res; 1996 Jun; 14(2):95-100. PubMed ID: 8870402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of stable LamB-Shiga toxin B subunit hybrids: analysis of expression in Salmonella typhimurium aroA strains and stimulation of B subunit-specific mucosal and serum antibody responses.
    Su GF; Brahmbhatt HN; Wehland J; Rohde M; Timmis KN
    Infect Immun; 1992 Aug; 60(8):3345-59. PubMed ID: 1639503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody to Shigella dysenteriae serotype 13 cross-reacting with Shiga toxin.
    Qadri F; Azim T; Hossain A; Islam D; Mondol G; Faruque SM; Albert MJ
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):343-7. PubMed ID: 8472916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography.
    O'Brien AD; LaVeck GD; Griffin DE; Thompson MR
    Infect Immun; 1980 Oct; 30(1):170-9. PubMed ID: 7002787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies.
    Donohue-Rolfe A; Keusch GT; Edson C; Thorley-Lawson D; Jacewicz M
    J Exp Med; 1984 Dec; 160(6):1767-81. PubMed ID: 6392471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against recombinant shiga toxin subunit B neutralize shiga toxin toxicity in HeLa cells.
    Gupta P; Singh MK; Singh P; Tiwari M; Dhaked RK
    Protein Pept Lett; 2010 Jun; 17(6):774-81. PubMed ID: 20044923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of monoclonal antibodies with therapeutic potential against Shiga toxin.
    Islam MS; Stimson WH
    J Clin Lab Immunol; 1990 Sep; 33(1):11-6. PubMed ID: 1966939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity.
    Perera LP; Samuel JE; Holmes RK; O'Brien AD
    J Bacteriol; 1991 Feb; 173(3):1151-60. PubMed ID: 1991714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin.
    Noda M; Yutsudo T; Nakabayashi N; Hirayama T; Takeda Y
    Microb Pathog; 1987 May; 2(5):339-49. PubMed ID: 3148810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Shiga toxin epitopes in E. coli immunological characterization.
    McEwen J; Leitner M; Harari I; Arnon R
    Immunol Lett; 1989 May; 21(2):157-63. PubMed ID: 2475438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral immunization of mice with Lactococcus lactis expressing Shiga toxin truncate confers enhanced protection against Shiga toxins of Escherichia coli O157:H7 and Shigella dysenteriae.
    Sreerohini S; Balakrishna K; Parida M
    APMIS; 2019 Oct; 127(10):671-680. PubMed ID: 31344276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.